Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study.

Abstract	The aim of this study was to evaluate the efficacy of palifermin, an N-terminal truncated version of endogenous keratinocyte growth factor, in the control of oral mucositis during antiblastic therapy. Twenty patients undergoing allogeneic stem-cell transplantation for acute lymphoblastic leukaemia were treated with palifermin, and compared to a control group with the same number of subjects and similar inclusion criteria. Statistical analysis were performed to compare the outcomes in the treatment vs. control groups. In the treatment group, we found a statistically significant reduction in the duration of parenteral nutrition (P=0.002), duration of mucositis (P=0.003) and the average grade of mucositis (P=0.03). The statistical analysis showed that the drug was able to decrease the severity of mucositis. These data, although preliminary, suggest that palifermin could be a valid therapeutic adjuvant to improve the quality of life of patients suffering from leukaemia.
Authors	Dorina Lauritano, Massimo Petruzzi, Dario Di Stasio, Alberta Lucchese
Journal	International journal of oral science (Int J Oral Sci) Vol. 6 Issue 1 Pg. 27-30 (Mar 2014) ISSN: 1674-2818 [Print] India
PMID	24357856 (Publication Type: Comparative Study, Journal Article)
Chemical References	Anti-Inflammatory Agents Myeloablative Agonists Fibroblast Growth Factor 7 Cyclophosphamide
Topics	Adolescent Allografts (transplantation) Anti-Inflammatory Agents (therapeutic use) Case-Control Studies Child Cohort Studies Cyclophosphamide (therapeutic use) Female Fibroblast Growth Factor 7 (therapeutic use) Hematopoietic Stem Cell Transplantation (methods) Humans Male Myeloablative Agonists (therapeutic use) Parenteral Nutrition Precursor Cell Lymphoblastic Leukemia-Lymphoma (therapy) Radiotherapy Dosage Stomatitis (classification, drug therapy, prevention & control) Time Factors Transplantation Conditioning (methods) Treatment Outcome Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!